RNA, U6 small nuclear 166, pseudogene (RNU6-166P)

RNU6-166P is a **pseudogene** of the U6 small nuclear RNA family, annotated as "RNA, U6 small nuclear 166, pseudogene." U6 small nuclear RNA (U6 snRNA) itself is an essential, highly conserved component of the spliceosome involved in pre-mRNA splicing in eukaryotic cells, and is one of the five major spliceosomal snRNAs (U1, U2, U4, U5, U6)[1][2][3]. However, RNU6-166P encodes a **pseudogene**—an inactive, non-functional copy—of the U6 snRNA gene. Pseudogenes like RNU6-166P do not produce functional RNA or protein and are not considered genuine molecular or therapeutic targets. They generally lack known biological function, do not participate in cellular signaling or enzymatic activity, and are not associated with disease mechanisms or targeted by drugs. Human genomes contain many U6 snRNA pseudogenes, reflecting the evolutionary importance and redundancy of U6 snRNA[2]. Functional U6 snRNA (not the pseudogene) plays a crucial role in the catalytic steps of RNA splicing[1][2]. The pseudogene RNU6-166P, by contrast, does not code for an active snRNA molecule and therefore is not expected to participate in such processes. There is no evidence that RNU6-166P acts as a disease driver, therapeutic target, or biomarker, nor are there safety concerns related to it in medical contexts. **Note:** - This entry is marked as a pseudogene and is therefore not suitable as a therapeutic target, biomarker, or direct subject of drug interaction or mechanism studies. - If your underlying intent was to refer to the functional U6 snRNA, information should be structured around RNU6-1 (the canonical gene for functional U6 snRNA)[1][2][4].

Other names

RNU6-166PU6 snRNA pseudogene 166U6-166P